Company Filing History:
2 out of 22 
2 out of 28 Years Active: 2019
Title: Jean-Baptiste Barbaroux: Innovator in Biochemical Engineering
Introduction
Jean-Baptiste Barbaroux is a notable inventor based in Marseilles, France. He has made significant contributions to the field of biochemical engineering, particularly in the development of enzyme variants that enhance the production of valuable chemical compounds. With a total of 2 patents, his work is paving the way for advancements in bioenergetics.
Latest Patents
Barbaroux's latest patents include innovations in HIV kinase variants and HIV synthase variants. The HIV kinase variants demonstrate improved activity in converting 3-hydroxyisovalerate (HIV) into 3-phosphonoxyisovalerate (PIV). These patents also detail methods for producing PIV using these enzyme variants, as well as subsequent methods for producing isobutene. Additionally, the HIV synthase variants exhibit enhanced activity in converting acetone and an activated acetyl group into 3-hydroxyisovalerate (HIV). The patents further describe methods for producing 3-hydroxyisovalerate and isobutene from acetone utilizing these innovative enzyme variants.
Career Highlights
Throughout his career, Barbaroux has worked with prominent companies in the field, including Global Bioenergies and Scientist of Fortune, S.A. His expertise in biochemical processes has positioned him as a key player in the development of sustainable chemical production methods.
Collaborations
Barbaroux has collaborated with notable professionals in his field, including Sabine Mazaleyrat and Marc Delcourt. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Jean-Baptiste Barbaroux is a distinguished inventor whose work in enzyme variants is making a significant impact in biochemical engineering. His innovative patents and collaborations highlight his commitment to advancing sustainable chemical production.